ISPOR EU 2025: What did we learn? Part 2/2

In a recent post, we talked about the need for high-quality Real-World Data.

However, there was another central topic at this year’s ISPOR conference: Artificial Intelligence.

We experience every day how AI is transforming our work — the way we prepare documents, plan and implement studies, and communicate with each other. However — and this was our second major learning — expert validation remains a critical component of every AI-driven solution. Hallucinations and the intrinsic limitations of AI present risks that require expert oversight and management.

With the development of our Evidence Synthesis platform ANCHOR, we fully embraced this principle and are ahead — our built-in AI “third reviewer” works alongside two human reviewers to enhance the robustness of SLRs, with every extraction field fully transparent and human-validated. Early insights. Greater rigour. Next-generation HEOR, delivered.

If you don’t want to wait until the next ISPOR to learn more, feel free to reach out to us!

info@gipam-health.com

Next
Next

ISPOR EU 2025: What did we learn? Part 1/2